CTOs on the Move

HMA Inc

www.hma-inc.com

 
HMA Inc is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.hma-inc.com
  • 1600 W Broadway Rd Ste 300
    Tempe, AZ USA 85282
  • Phone: 480.921.8944

Executives

Name Title Contact Details

Similar Companies

St. Ann`s Community

St. Ann`s Community is Rochester`s leading senior housing and health services provider, with a tradition of quality care for older adults dating back to 1873. St. Ann`s offers a continuum of care that includes independent retirement living, assisted living, skilled nursing, memory care, short-term transitional care, palliative care, and adult day programs. One of the area`s largest employers, St. Ann`s has more than 1,200 employees who are "Caring for the Most Important People on Earth."

Mental Health Centers of Western Illinois

Mental Health Centers of Western Illinois has been organized to effectively and efficiently serve the behavioral healthcare needs of small and rural communities in Western Illinois. The mission of the Mental Health Centers of Western Illinois is to

Acumentra Health

Acumentra Health is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zotos International, Inc.

Zotos International, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Darien, CT. To find more information about Zotos International, Inc., please visit www.zotos.com

HedgePath Pharmaceuticals

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.